BACKGROUNDLicense, Development and Distribution Agreement • April 15th, 2005 • Treasure Mountain Holdings Inc • Surgical & medical instruments & apparatus • Pennsylvania
Contract Type FiledApril 15th, 2005 Company Industry Jurisdiction
MICRUS ENDOVASCULAR CORPORATION and BIOTRONIK AG LICENSE, DEVELOPMENT and DISTRIBUTION AGREEMENT As of January 6, 2006License, Development and Distribution Agreement • June 16th, 2006 • Micrus Endovascular Corp • Surgical & medical instruments & apparatus
Contract Type FiledJune 16th, 2006 Company IndustryThis LICENSE, DEVELOPMENT AND DISTRIBUTION AGREEMENT (together with the attachments and exhibits hereto, the “Agreement”) is entered into as of January 6, 2006 (the “Effective Date”) by and between Micrus Endovascular Corporation, a corporation established under the laws of Delaware and having its principal place of business at 610 Palomar Avenue, Sunnyvale, CA 94085, USA (“Micrus”); and Biotronik AG, a Swiss corporation having a principal place of business at Ackerstrasse 6, CH-8180 Bülach, Switzerland (“Biotronik”).
LICENSE, DEVELOPMENT AND DISTRIBUTION AGREEMENT This Agreement is made as of March 9, 2018 (“Effective Date”) by and among QIAGEN LLC, a California limited liability company with its principal place of business at 19300 Germantown Road, Germantown, MD...License, Development and Distribution Agreement • May 10th, 2018 • Natera, Inc. • Services-medical laboratories • New York
Contract Type FiledMay 10th, 2018 Company Industry JurisdictionWHEREAS, QIAGEN and Natera [*] to develop versions of Natera’s proprietary diagnostic assays in a format that is compatible with QIAGEN’s Sequencing System (defined in Section 1 below); and
EXECUTION COPY LICENSE, DEVELOPMENT AND DISTRIBUTION AGREEMENT This Agreement is made as of March 9, 2018 (“Effective Date”) by and among QIAGEN LLC, a California limited liability company with its principal place of business at 19300 Germantown Road,...License, Development and Distribution Agreement • February 6th, 2019 • Natera, Inc. • Services-medical laboratories • New York
Contract Type FiledFebruary 6th, 2019 Company Industry JurisdictionWHEREAS, QIAGEN and Natera [*] to develop versions of Natera’s proprietary diagnostic assays in a format that is compatible with QIAGEN’s Sequencing System (defined in Section 1 below); and